| Element List | Explanation |
|---|---|
| Introduction | With reference to the Company’s announcement published on the Saudi Exchange (Tadawul) website on 13 September 2018 regarding the commencement of commercial production of the tablets and liquids lines of the first phase (which includes three lines: tablets, liquids, and creams) at the plant of AJA Pharmaceutical Industries Company (a subsidiary). Saudi Chemical Company Holding announces, through its subsidiary AJA Pharmaceutical Industries Company (AJA Pharma), the completion of the trial phase and the commencement of the initial operation of the fourth line—the advanced sterile injectables line—following the successful production of the first experimental batches in accordance with approved standards. |
| Previous Announcement | A supplementary announcement from Saudi Chemical Company regarding the commencement of commercial production at the plant of AJA Pharmaceutical Industries Company (a subsidiary). |
| Date of Previous Announcement on Saudi Exchange’s Website | 2018-09-13 Corresponding to 1440-01-03 |
| Hyperlink to the Previous Announcement on the Saudi Exchange Website | Click Here |
| Latest Developments Of The Announced Event | The commencement of the start-up phase for the advanced sterile injectables line, following the completion of technical and operational trials and the successful production of the first experimental batches, as part of the implementation stages of the pharmaceuticals and medical preparations manufacturing project. This development represents an initial operational phase within the project implementation plan and aims to enhance manufacturing capabilities in the pharmaceutical sector and contribute to the localization of high value-added pharmaceutical manufacturing, in line with the objectives of Saudi Vision 2030. The Company clarifies that this phase does not constitute the commencement of commercial production, and an announcement in this regard will be made in due course after the completion of the relevant regulatory and operational requirements. |
| Reasons For The Delay on The Date of The Event Previously Announced | Not applicable |
| The costs associated with the event, and if they have changed or not with indication of the reasons. | There is no material change in the costs associated with the project compared to what was previously announced; however, it is expected to have a positive impact on the company once commercial operations commence. |
| Delay consequences on the Company’s financial results | Not applicable |